Zeng, Musheng; Kumar Ajay; et al. (2002). „Human papilloma virus 16 E6 oncoprotein inhibits retinoic X receptor-mediated transactivation by targeting human ADA3 coactivator”. J. Biol. Chem. United States. 277 (47): 45611—8. ISSN0021-9258. PMID12235159. doi:10.1074/jbc.M208447200.
Martin; Delmotte; et al. (2003). „PLZF is a negative regulator of retinoic acid receptor transcriptional activity”. Nucl. Recept. 1 (1): 6. PMID14521715. doi:10.1186/1478-1336-1-6.
Despouy, Gilles; Bastie Jean-Nöel; et al. (2003). „Cyclin D3 is a cofactor of retinoic acid receptors, modulating their activity in the presence of cellular retinoic acid-binding protein II”. J. Biol. Chem. United States. 278 (8): 6355—62. ISSN0021-9258. PMID12482873. doi:10.1074/jbc.M210697200.
Hu, Xinli; Chen Yixin; et al. (2004). „Suppressive effect of receptor-interacting protein 140 on coregulator binding to retinoic acid receptor complexes, histone-modifying enzyme activity, and gene activation”. J. Biol. Chem. United States. 279 (1): 319—25. ISSN0021-9258. PMID14581481. doi:10.1074/jbc.M307621200.
Farooqui, Mariya; Franco Peter J; et al. (2003). „Effects of retinoid ligands on RIP140: molecular interaction with retinoid receptors and biological activity”. Biochemistry. United States. 42 (4): 971—9. ISSN0006-2960. PMID12549917. doi:10.1021/bi020497k.
Zhong, S; Delva L; et al. (1999). „A RA-dependent, tumour-growth suppressive transcription complex is the target of the PML-RARalpha and T18 oncoproteins”. Nat. Genet. UNITED STATES. 23 (3): 287—95. ISSN1061-4036. PMID10610177. doi:10.1038/15463.
nih.gov
ncbi.nlm.nih.gov
Lee, S K; Jung S Y; et al. (2001). „Two distinct nuclear receptor-interaction domains and CREB-binding protein-dependent transactivation function of activating signal cointegrator-2”. Mol. Endocrinol. United States. 15 (2): 241—54. ISSN0888-8809. PMID11158331.
Lee, S K; Anzick S L; et al. (1999). „A nuclear factor, ASC-2, as a cancer-amplified transcriptional coactivator essential for ligand-dependent transactivation by nuclear receptors in vivo”. J. Biol. Chem. UNITED STATES. 274 (48): 34283—93. ISSN0021-9258. PMID10567404.
Ko, L; Cardona G R; Chin W W (2000). „Thyroid hormone receptor-binding protein, an LXXLL motif-containing protein, functions as a general coactivator”. Proc. Natl. Acad. Sci. U.S.A. UNITED STATES. 97 (11): 6212—7. ISSN0027-8424. PMID10823961.
McNamara, P; Seo S B; et al. (2001). „Regulation of CLOCK and MOP4 by nuclear hormone receptors in the vasculature: a humoral mechanism to reset a peripheral clock”. Cell. United States. 105 (7): 877—89. ISSN0092-8674. PMID11439184.
Zeng, Musheng; Kumar Ajay; et al. (2002). „Human papilloma virus 16 E6 oncoprotein inhibits retinoic X receptor-mediated transactivation by targeting human ADA3 coactivator”. J. Biol. Chem. United States. 277 (47): 45611—8. ISSN0021-9258. PMID12235159. doi:10.1074/jbc.M208447200.
Martin; Delmotte; et al. (2003). „PLZF is a negative regulator of retinoic acid receptor transcriptional activity”. Nucl. Recept. 1 (1): 6. PMID14521715. doi:10.1186/1478-1336-1-6.
Perlmann, T; Jansson L (1995). „A novel pathway for vitamin A signaling mediated by RXR heterodimerization with NGFI-B and NURR1”. Genes Dev. UNITED STATES. 9 (7): 769—82. ISSN0890-9369. PMID7705655.
Seol, W; Choi H S; Moore D D (1996). „An orphan nuclear hormone receptor that lacks a DNA binding domain and heterodimerizes with other receptors”. Science. UNITED STATES. 272 (5266): 1336—9. ISSN0036-8075. PMID8650544.
Seol, W; Hanstein B; et al. (1998). „Inhibition of estrogen receptor action by the orphan receptor SHP (short heterodimer partner)”. Mol. Endocrinol. UNITED STATES. 12 (10): 1551—7. ISSN0888-8809. PMID9773978.
Despouy, Gilles; Bastie Jean-Nöel; et al. (2003). „Cyclin D3 is a cofactor of retinoic acid receptors, modulating their activity in the presence of cellular retinoic acid-binding protein II”. J. Biol. Chem. United States. 278 (8): 6355—62. ISSN0021-9258. PMID12482873. doi:10.1074/jbc.M210697200.
Dowell, P; Ishmael J E; et al. (1999). „Identification of nuclear receptor corepressor as a peroxisome proliferator-activated receptor alpha interacting protein”. J. Biol. Chem. UNITED STATES. 274 (22): 15901—7. ISSN0021-9258. PMID10336495.
Guidez, F; Ivins S; et al. (1998). „Reduced retinoic acid-sensitivities of nuclear receptor corepressor binding to PML- and PLZF-RARalpha underlie molecular pathogenesis and treatment of acute promyelocytic leukemia”. Blood. UNITED STATES. 91 (8): 2634—42. ISSN0006-4971. PMID9531570.
Liu, R; Takayama S; et al. (1998). „Interaction of BAG-1 with retinoic acid receptor and its inhibition of retinoic acid-induced apoptosis in cancer cells”. J. Biol. Chem. UNITED STATES. 273 (27): 16985—92. ISSN0021-9258. PMID9642262.
Dong, Shuo; Tweardy David J (2002). „Interactions of STAT5b-RARalpha, a novel acute promyelocytic leukemia fusion protein, with retinoic acid receptor and STAT3 signaling pathways”. Blood. United States. 99 (8): 2637—46. ISSN0006-4971. PMID11929748.
Hong, S H; David G; et al. (1997). „SMRT corepressor interacts with PLZF and with the PML-retinoic acid receptor alpha (RARalpha) and PLZF-RARalpha oncoproteins associated with acute promyelocytic leukemia”. Proc. Natl. Acad. Sci. U.S.A. UNITED STATES. 94 (17): 9028—33. ISSN0027-8424. PMID9256429.
Hu, Xinli; Chen Yixin; et al. (2004). „Suppressive effect of receptor-interacting protein 140 on coregulator binding to retinoic acid receptor complexes, histone-modifying enzyme activity, and gene activation”. J. Biol. Chem. United States. 279 (1): 319—25. ISSN0021-9258. PMID14581481. doi:10.1074/jbc.M307621200.
Farooqui, Mariya; Franco Peter J; et al. (2003). „Effects of retinoid ligands on RIP140: molecular interaction with retinoid receptors and biological activity”. Biochemistry. United States. 42 (4): 971—9. ISSN0006-2960. PMID12549917. doi:10.1021/bi020497k.
Zhong, S; Delva L; et al. (1999). „A RA-dependent, tumour-growth suppressive transcription complex is the target of the PML-RARalpha and T18 oncoproteins”. Nat. Genet. UNITED STATES. 23 (3): 287—95. ISSN1061-4036. PMID10610177. doi:10.1038/15463.
Lee, S K; Jung S Y; et al. (2001). „Two distinct nuclear receptor-interaction domains and CREB-binding protein-dependent transactivation function of activating signal cointegrator-2”. Mol. Endocrinol. United States. 15 (2): 241—54. ISSN0888-8809. PMID11158331.
Lee, S K; Anzick S L; et al. (1999). „A nuclear factor, ASC-2, as a cancer-amplified transcriptional coactivator essential for ligand-dependent transactivation by nuclear receptors in vivo”. J. Biol. Chem. UNITED STATES. 274 (48): 34283—93. ISSN0021-9258. PMID10567404.
Ko, L; Cardona G R; Chin W W (2000). „Thyroid hormone receptor-binding protein, an LXXLL motif-containing protein, functions as a general coactivator”. Proc. Natl. Acad. Sci. U.S.A. UNITED STATES. 97 (11): 6212—7. ISSN0027-8424. PMID10823961.
McNamara, P; Seo S B; et al. (2001). „Regulation of CLOCK and MOP4 by nuclear hormone receptors in the vasculature: a humoral mechanism to reset a peripheral clock”. Cell. United States. 105 (7): 877—89. ISSN0092-8674. PMID11439184.
Zeng, Musheng; Kumar Ajay; et al. (2002). „Human papilloma virus 16 E6 oncoprotein inhibits retinoic X receptor-mediated transactivation by targeting human ADA3 coactivator”. J. Biol. Chem. United States. 277 (47): 45611—8. ISSN0021-9258. PMID12235159. doi:10.1074/jbc.M208447200.
Perlmann, T; Jansson L (1995). „A novel pathway for vitamin A signaling mediated by RXR heterodimerization with NGFI-B and NURR1”. Genes Dev. UNITED STATES. 9 (7): 769—82. ISSN0890-9369. PMID7705655.
Seol, W; Choi H S; Moore D D (1996). „An orphan nuclear hormone receptor that lacks a DNA binding domain and heterodimerizes with other receptors”. Science. UNITED STATES. 272 (5266): 1336—9. ISSN0036-8075. PMID8650544.
Seol, W; Hanstein B; et al. (1998). „Inhibition of estrogen receptor action by the orphan receptor SHP (short heterodimer partner)”. Mol. Endocrinol. UNITED STATES. 12 (10): 1551—7. ISSN0888-8809. PMID9773978.
Despouy, Gilles; Bastie Jean-Nöel; et al. (2003). „Cyclin D3 is a cofactor of retinoic acid receptors, modulating their activity in the presence of cellular retinoic acid-binding protein II”. J. Biol. Chem. United States. 278 (8): 6355—62. ISSN0021-9258. PMID12482873. doi:10.1074/jbc.M210697200.
Dowell, P; Ishmael J E; et al. (1999). „Identification of nuclear receptor corepressor as a peroxisome proliferator-activated receptor alpha interacting protein”. J. Biol. Chem. UNITED STATES. 274 (22): 15901—7. ISSN0021-9258. PMID10336495.
Guidez, F; Ivins S; et al. (1998). „Reduced retinoic acid-sensitivities of nuclear receptor corepressor binding to PML- and PLZF-RARalpha underlie molecular pathogenesis and treatment of acute promyelocytic leukemia”. Blood. UNITED STATES. 91 (8): 2634—42. ISSN0006-4971. PMID9531570.
Liu, R; Takayama S; et al. (1998). „Interaction of BAG-1 with retinoic acid receptor and its inhibition of retinoic acid-induced apoptosis in cancer cells”. J. Biol. Chem. UNITED STATES. 273 (27): 16985—92. ISSN0021-9258. PMID9642262.
Dong, Shuo; Tweardy David J (2002). „Interactions of STAT5b-RARalpha, a novel acute promyelocytic leukemia fusion protein, with retinoic acid receptor and STAT3 signaling pathways”. Blood. United States. 99 (8): 2637—46. ISSN0006-4971. PMID11929748.
Hong, S H; David G; et al. (1997). „SMRT corepressor interacts with PLZF and with the PML-retinoic acid receptor alpha (RARalpha) and PLZF-RARalpha oncoproteins associated with acute promyelocytic leukemia”. Proc. Natl. Acad. Sci. U.S.A. UNITED STATES. 94 (17): 9028—33. ISSN0027-8424. PMID9256429.
Hu, Xinli; Chen Yixin; et al. (2004). „Suppressive effect of receptor-interacting protein 140 on coregulator binding to retinoic acid receptor complexes, histone-modifying enzyme activity, and gene activation”. J. Biol. Chem. United States. 279 (1): 319—25. ISSN0021-9258. PMID14581481. doi:10.1074/jbc.M307621200.
Farooqui, Mariya; Franco Peter J; et al. (2003). „Effects of retinoid ligands on RIP140: molecular interaction with retinoid receptors and biological activity”. Biochemistry. United States. 42 (4): 971—9. ISSN0006-2960. PMID12549917. doi:10.1021/bi020497k.
Zhong, S; Delva L; et al. (1999). „A RA-dependent, tumour-growth suppressive transcription complex is the target of the PML-RARalpha and T18 oncoproteins”. Nat. Genet. UNITED STATES. 23 (3): 287—95. ISSN1061-4036. PMID10610177. doi:10.1038/15463.